Epilepsy is one of the most common neurological disorders globally. According to the WHO, it affects over 50 million people with 80% of those living in low to middle income countries (LMICs). Additionally, around 15 million women of reproductive age live with epilepsy, making it the most common serious neurological condition encountered in pregnancy.
Epilepsy remains underdiagnosed, undertreated and poorly understood, particularly in LMICs, where there are shortages of neurologists, diagnostic tools and essential medications. Through the collection of comprehensive, standardised data on epilepsy and pregnancy outcomes, the MOMENTUM study will help inform national policy, shape culturally sensitive approaches to treatment and contribute to global efforts to address epilepsy and maternal health in countries, such as Nepal, where resource is limited.
Bringing together researchers from NDCN, Nuffield Department of Women’s and Reproductive Health, the Centre for Global Epilepsy and the Nepal Public Health Foundation (NPHF), the study will also build much needed research capacity in Nepal and strengthen international collaboration.
Read the full story on the Nuffield Department of Clinical Neuroscience website.
